Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bionicjoeon Jul 03, 2019 5:43pm

78 Views

Post# 29884799

RE:Market punishes uncertainty

Nobody thought to ask at the AGM why they are offering 5 year warrants when the clinical trial is only scheduled to go on for 3 years?

A Bought Deal with one or two of the investment banks for the full $15 million would have been a more efficient process. Had they tried is another question that could have been asked.

Bullboard Posts

Stockhouse DealRoom opens new Australian opportunities